Search
Paige Arnold, a graduate student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), is one of 13 PhD candidates selected from around the world to receive a Harold M. Weintraub Graduate Student Award for the quality, originality, and significance of their doctoral research.
Studies conducted in mice reveal a potential way to breach the defenses of pancreatic cancer tumors.
Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective.
The third annual research symposium introduces high school students and teachers to several topics in cancer research.
Learn about the work of Mehmet Erman Karasu, a recent graduate of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), has been awarded the 2019 Chairman’s Prize.
Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist.
Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.
A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes.
The award recognizes his lifetime contributions to the field of life sciences, especially related to the training of Chinese scientists who have returned to faculty positions in China.